Intervention
GSK573719
ClinicalTrials.gov intervention label
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov intervention label, found in 10 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
10 shownAura Adolescent PK Study GSK2829332NCT01653483 · 2012-09-01
WITHDRAWNLong-term Safety Study for GSK573719 in JapaneseNCT01702363 · 2012-08-01
COMPLETEDQTc Study GSK573719+GW642444NCT01521377 · 2011-12-19
COMPLETEDEvaluate the Efficacy and Safety of GSK573719 Delivered Via a Novel Dry Powder Inhaler in Subjects With COPDNCT01387230 · 2011-07-01
COMPLETEDA Randomized, Double Blind, Placebo Controlled, Incomplete Block, Crossover, Dose Ranging Study to Evaluate the Dose Response of GSK573719 Administered Once or Twice Daily Over 7 Days in Patients With Chronic Obstructive Pulmonary Disease (COPD)NCT01372410 · 2011-07-01
COMPLETED24-week Trial Comparing GSK573719/GW642444 With GSK573719 and With Tiotropium in Chronic Obstructive Pulmonary DiseaseNCT01316913 · 2011-03-01
COMPLETEDSafety, Tolerability, Pharmacokinetic and Pharmacodynamic Effects of GSK573719 (LAMA) and GW642444 (LABA)Administered Individually and Concurrently in Healthy Japanese SubjectsNCT00976144 · 2009-07-29
COMPLETEDA Study to Assess the Safety and Tolerability of Once Daily Inhaled Doses of GSK573719 Made With Magnesium Stearate in Subjects With Chronic Obstructive Pulmonary Disease(COPD)for 7 DaysNCT00732472 · 2008-10-01
COMPLETEDSafety Study Using GSK573719 And Tiotropium In Patients With Chronic Obstructive Pulmonary DiseaseNCT00515502 · 2007-06-21
COMPLETEDA Single Centre Randomized Study Evaluating The Safety And Tolerability Of GSK573719 In Healthy VolunteersNCT00475436 · 2007-05-14
COMPLETEDCommon conditions
Leading sponsors
Trial status mix
COMPLETED9
WITHDRAWN1
Phase mix
PHASE24
PHASE13
PHASE33
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.